← Open Payments lookup

MARISSA GENOVESE: Open Payments

NPI 1629805742 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,003 in 220 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $273 · 2025 $4,003

Food & beverage: $3,891Education: $111
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.27$603
Teva Pharmaceuticals USA, Inc.27$560
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)15$364
Alkermes, Inc.15$277
Janssen Pharmaceuticals, Inc14$268
Axsome Therapeutics, Inc.15$266
ABBVIE INC.22$255
Vanda Pharmaceuticals Inc.9$218
Almatica Pharma LLC14$215
Bausch Health US, LLC10$211

Products named: INGREZZA, AUSTEDO XR, CAPLYTA, REXULTI, Auvelity, ARISTADA, FANAPT, LOREEV XR.

Industry payments across OR — which companies pay providers there.